It is a pharma private limited company based in Lucknow, Uttar Pradesh, India, established in 2015.
2015 | Lucknow, Uttar Pradesh, India | ActiveMaximakare Lifesciences Private Limited, a active private limited company, was established on 01 April 2015 in Lucknow, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the professional, scientific and technical sector, it holds CIN: U74120UP2015PTC069907. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a active non-compliant status. Its leadership includes Ritu Srivastava (Managing Director), Roop Chand Rastogi (Managing Director). Past directors included Jayant Gupta, Anshuman Srivastava. It holds no open charges and ₹9.00 M settled loans. Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at D-63, Rajajipuram, Lucknow, Uttar Pradesh, 226017.
U74120UP2015PTC069907
069907
01 April 2015
₹1.00 M
₹1.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Maximakare Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ritu Srivastava | Managing Director | 16 Jan 2016 | Current |
| Roop Chand Rastogi | Managing Director | 01 Apr 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 30 Nov 2017 | Past |
| Pramod Abcsdd | Managing Director | 24 Dec 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Maximakare Lifesciences Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 206.89% increase. The company also saw a substantial fall in profitability, with a 24.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 172.28%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Maximakare Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹9,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jan 2016 | Canara Bank | ₹9.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Maximakare Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Maximakare Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maximakare Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 20 Jan 2016 via Charge ID 10618381 with Canara Bank was fully satisfied on 11 Jan 2022. was completed.
The activity A charge with Canara Bank of Rs. 9.00 M registered on 20 Jan 2016 with Charge ID 10618381 was modified on 20 Dec 2017. was completed.
Progress on Maximakare Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was documented.
The activity Maximakare Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Kanpur. was completed.
A charge with Canara Bank amounted to Rs. 9.00 M with Charge ID 10618381 was registered on 20 Jan 2016. was recorded as a recent event.
Ritu Srivastava was appointed as a Managing Director was appointed as a Managing Director on 16 Jan 2016 & has been associated with this company since 9 years 11 months . was recorded as a recent event.
The CIN of Maximakare Lifesciences Private Limited is U74120UP2015PTC069907.
Maximakare Lifesciences Private Limited is headquartered at D-63, Rajajipuram, Lucknow, Uttar Pradesh, 226017.
Maximakare Lifesciences Private Limited was incorporated on 01 April 2015.
The current directors of Maximakare Lifesciences Private Limited are
The primary industry of Maximakare Lifesciences Private Limited is Professional, Scientific And Technical.
Maximakare Lifesciences Private Limited is unlisted.
The authorized capital of Maximakare Lifesciences Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Maximakare Lifesciences Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX